PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.\', \'Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria.\', \'Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria.\', \'Rare Liver Disease (RALID) Centre of the ERN RARE-LIVER, Medical University of Vienna, Vienna, Austria.\', \'Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0256544
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 34437610
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all